BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cody EM, Dixon BP. Hemolytic Uremic Syndrome. Pediatric Clinics of North America 2019;66:235-46. [DOI: 10.1016/j.pcl.2018.09.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Ersoy Dursun F, Yesil G, Sasak G, Dursin H. Familial Atypical Hemolytic Uremic Syndrome with Positive p.S1191L (c.3572C>T) Mutation on the CFH Gene: A Single-center Experience. Balkan J Med Genet 2021;24:81-8. [PMID: 34447663 DOI: 10.2478/bjmg-2021-0007] [Reference Citation Analysis]
2 López-Trascasa M, Alonso-Melgar Á, Melgosa-Hijosa M, Espinosa-Román L, Lledín-Barbancho MD, García-Fernández E, Rodríguez de Córdoba S, Sánchez-Corral P. Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient. Front Immunol 2021;12:751093. [PMID: 34721423 DOI: 10.3389/fimmu.2021.751093] [Reference Citation Analysis]
3 Sánchez DS, Fischer Sigel LK, Balestracci A, Ibarra C, Amaral MM, Silberstein C. Eliglustat prevents Shiga toxin 2 cytotoxic effects in human renal tubular epithelial cells. Pediatr Res 2021. [PMID: 34155339 DOI: 10.1038/s41390-021-01622-3] [Reference Citation Analysis]
4 Bertola EA, Simonetti GD, Del Giorno R, Giannini O, Fossali EF, Meoli M, Bianchetti MG, Terziroli Beretta-piccoli B, Milani GP. Extrarenal Immune-Mediated Disorders Linked with Acute Poststreptococcal Glomerulonephritis: a Systematic Review. Clinic Rev Allerg Immunol 2019;57:294-302. [DOI: 10.1007/s12016-019-08761-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Luz D, Gómez FD, Ferreira RL, Melo BS, Guth BEC, Quintilio W, Moro AM, Presta A, Sacerdoti F, Ibarra C, Chen G, Sidhu SS, Amaral MM, Piazza RMF. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody. Toxins (Basel) 2021;13:825. [PMID: 34822608 DOI: 10.3390/toxins13110825] [Reference Citation Analysis]
6 Tahir MA, Dina NE, Cheng H, Valev VK, Zhang L. Surface-enhanced Raman spectroscopy for bioanalysis and diagnosis. Nanoscale 2021;13:11593-634. [PMID: 34231627 DOI: 10.1039/d1nr00708d] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mikolajczyk K, Bereznicka A, Szymczak-Kulus K, Haczkiewicz-Lesniak K, Szulc B, Olczak M, Rossowska J, Majorczyk E, Kapczynska K, Bovin N, Lisowska M, Kaczmarek R, Miazek A, Czerwinski M. Missing the sweet spot: one of the two N-glycans on human Gb3/CD77 synthase is expendable. Glycobiology 2021:cwab041. [PMID: 33978735 DOI: 10.1093/glycob/cwab041] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ruas AFL, Lébeis GM, de Castro NB, Palmeira VA, Costa LB, Lanza K, Simões E Silva AC. Acute kidney injury in pediatrics: an overview focusing on pathophysiology. Pediatr Nephrol 2021. [PMID: 34845510 DOI: 10.1007/s00467-021-05346-8] [Reference Citation Analysis]
9 Galarce N, Sánchez F, Escobar B, Lapierre L, Cornejo J, Alegría-Morán R, Neira V, Martínez V, Johnson T, Fuentes-Castillo D, Sano E, Lincopan N. Genomic Epidemiology of Shiga Toxin-Producing Escherichia coli Isolated from the Livestock-Food-Human Interface in South America. Animals (Basel) 2021;11:1845. [PMID: 34206206 DOI: 10.3390/ani11071845] [Reference Citation Analysis]
10 Veríssimo R, Mateus C, Laranjinha I, Manso RT, Dickson J, Gonçalves M, Gaspar MA, Machado D. Thrombotic microangiopathy triggered by podocytopathy. Clin Nephrol Case Stud 2021;9:110-6. [PMID: 34646728 DOI: 10.5414/CNCS110534] [Reference Citation Analysis]
11 Detzner J, Pohlentz G, Müthing J. Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome. Toxins (Basel) 2020;12:E373. [PMID: 32512916 DOI: 10.3390/toxins12060373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 van den Broek B, van der Flier M, de Groot R, de Jonge MI, Langereis JD. Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial Infection. J Innate Immun 2020;12:131-41. [PMID: 31269507 DOI: 10.1159/000500545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Pepper RJ, Trompeter RS. The causes and consequences of paediatric kidney disease on adult nephrology care. Pediatr Nephrol 2021. [PMID: 34389906 DOI: 10.1007/s00467-021-05182-w] [Reference Citation Analysis]
14 Gholizad-Kolveiri S, Hooman N, Alizadeh R, Hoseini R, Otukesh H, Talebi S, Akouchekian M. Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome. BMC Med Genet 2020;21:169. [PMID: 32838746 DOI: 10.1186/s12881-020-01097-9] [Reference Citation Analysis]
15 Hummel K, Glotzbach K, Menon S, Griffiths E, Lal AK. Thrombotic microangiopathy following heart transplant in pediatric Danon disease. Pediatr Transplant 2020;24:e13669. [PMID: 32067323 DOI: 10.1111/petr.13669] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Agarwal HS, Latifi SQ. Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine. Pathogens 2021;10:727. [PMID: 34207609 DOI: 10.3390/pathogens10060727] [Reference Citation Analysis]
17 Volk CG, Cusmano PM, Bower RJ, Sanders T, Maves RC. Volume Resuscitation and Progression to Organ Failure in Shiga Toxin-Producing Escherichia coli Infection in Adults. Crit Care Explor 2021;3:e0423. [PMID: 34036274 DOI: 10.1097/CCE.0000000000000423] [Reference Citation Analysis]
18 Manrique-Caballero CL, Peerapornratana S, Formeck C, Del Rio-Pertuz G, Gomez Danies H, Kellum JA. Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill. Crit Care Clin 2020;36:333-56. [PMID: 32172817 DOI: 10.1016/j.ccc.2019.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
19 Fründt T, Leuffert J, Groth S, Rösch T, Steurer S, Lohse AW, Ullrich S, Lüth S. Low incidence of colonic complications after severe Shiga toxin-producing E. coli O104:H4 infection. Z Gastroenterol 2021. [PMID: 34820797 DOI: 10.1055/a-1545-5322] [Reference Citation Analysis]
20 Golomidova AK, Efimov AD, Kulikov EE, Kuznetsov AS, Belalov IS, Letarov AV. O antigen restricts lysogenization of non-O157 Escherichia coli strains by Stx-converting bacteriophage phi24B. Sci Rep 2021;11:3035. [PMID: 33542282 DOI: 10.1038/s41598-021-82422-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Szymczak-Kulus K, Weidler S, Bereznicka A, Mikolajczyk K, Kaczmarek R, Bednarz B, Zhang T, Urbaniak A, Olczak M, Park EY, Majorczyk E, Kapczynska K, Lukasiewicz J, Wuhrer M, Unverzagt C, Czerwinski M. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry. J Biol Chem 2021;296:100299. [PMID: 33460651 DOI: 10.1016/j.jbc.2021.100299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Thompson R, Peng L, Zarmbinski B, Tierney DM. Adult Shigatoxin-mediated hemolytic uremic syndrome masked by alcohol use and inflammatory bowel disease. BMJ Case Rep 2021;14:e244115. [PMID: 34413043 DOI: 10.1136/bcr-2021-244115] [Reference Citation Analysis]
23 Galarce N, Sánchez F, Fuenzalida V, Ramos R, Escobar B, Lapierre L, Paredes-Osses E, Arriagada G, Alegría-Morán R, Lincopán N, Fuentes-Castillo D, Vera-Leiva A, González-Rocha G, Bello-Toledo H, Borie C. Phenotypic and Genotypic Antimicrobial Resistance in Non-O157 Shiga Toxin-Producing Escherichia coli Isolated From Cattle and Swine in Chile. Front Vet Sci 2020;7:367. [PMID: 32754621 DOI: 10.3389/fvets.2020.00367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Cheng C, Chen L, Wen S, Lin Z, Jiang X. Case Report: Denys-Drash Syndrome With WT1 Causative Variant Presenting as Atypical Hemolytic Uremic Syndrome. Front Pediatr 2020;8:605889. [PMID: 33392118 DOI: 10.3389/fped.2020.605889] [Reference Citation Analysis]
25 Al-Shyoukh A, Younis M, Abughanimeh O, Tahboub M, Hamarshi MS. An Unusual Case of Diffuse Alveolar Hemorrhage as a Clinical Manifestation of Atypical Hemolytic Uremic Syndrome: A Case Report. Cureus 2019;11:e5059. [PMID: 31516771 DOI: 10.7759/cureus.5059] [Reference Citation Analysis]
26 Patel RA, Hall DA, Eichenseer S, Bailey M. Movement Disorders and Hematologic Diseases. Mov Disord Clin Pract 2021;8:193-207. [PMID: 33553488 DOI: 10.1002/mdc3.13129] [Reference Citation Analysis]
27 van den Broek B, van Els CACM, Kuipers B, van Aerde K, Henriet SS, de Groot R, de Jonge MI, Langereis JD, van der Flier M. Multi-component meningococcal serogroup B (MenB)-4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency. Clin Exp Immunol 2019;198:381-9. [PMID: 31487400 DOI: 10.1111/cei.13368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Tavasoli A, Zafaranloo N, Hoseini R, Otukesh H, Nakhaiee S. Frequency of neurological involvement in patients with/without diarrhea hemolytic uremic syndrome: A Systematic review and meta-analysis. Med J Islam Repub Iran 2021;35:91. [PMID: 34956937 DOI: 10.47176/mjiri.35.91] [Reference Citation Analysis]
29 Sánchez F, Fuenzalida V, Ramos R, Escobar B, Neira V, Borie C, Lapierre L, López P, Venegas L, Dettleff P, Johnson T, Fuentes-Castillo D, Lincopan N, Galarce N. Genomic features and antimicrobial resistance patterns of Shiga toxin-producing Escherichia coli strains isolated from food in Chile. Zoonoses Public Health 2021;68:226-38. [PMID: 33619864 DOI: 10.1111/zph.12818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]